Harrow Inc. stock popped Tuesday after the Nashville-based eyecare pharmaceutical company on Monday announced preliminary ...

Commenting on the announcement, Mark Baum, CEO, stated, “We were certainly looking forward to reporting our record financial performance for ...

NASHVILLE, Tenn., March 03, 2025--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its financial results for the fourth quarter ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

The eyecare pharmaceutical company said after the bell it expects to report a profit of $5 million to $7 million on revenue of $65 million to $67 million in the fourth quarter. Analysts surveyed by ...